Patents by Inventor Gareth Ackland

Gareth Ackland has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DIAGNOSTICS
    Publication number: 20230043193
    Abstract: The present invention relates to the detection or diagnosis of infection or inflammation in a patient. In particular, the invention provides methods that allow the detection of markers in a sample from a patient or subject, such as a blood sample, which will indicate whether the patient or subject has an infection or has an inflammatory response.
    Type: Application
    Filed: July 19, 2022
    Publication date: February 9, 2023
    Inventor: Gareth Ackland
  • Diagnostics
    Patent number: 11415573
    Abstract: The present invention relates to the detection or diagnosis of infection or inflammation in a patient. In particular, the invention provides methods that allow the detection of markers in a sample from a patient or subject, such as a blood sample, which will indicate whether the patient or subject has an infection or has an inflammatory response.
    Type: Grant
    Filed: July 8, 2015
    Date of Patent: August 16, 2022
    Assignee: QUEEN MARY UNIVERSITY OF LONDON
    Inventor: Gareth Ackland
  • DIAGNOSTICS
    Publication number: 20170184570
    Abstract: The present invention relates to the detection or diagnosis of infection or inflammation in a patient. In particular, the invention provides methods that allow the detection of markers in a sample from a patient or subject, such as a blood sample, which will indicate whether the patient or subject has an infection or has an inflammatory response.
    Type: Application
    Filed: July 8, 2015
    Publication date: June 29, 2017
    Applicant: UCL BUSINESS PLC
    Inventor: Gareth ACKLAND
  • Treatment of Inflammatory Diseases
    Publication number: 20080292580
    Abstract: An aqueous solution or at least one polyether polyol in a fluid for administration to a mammal, such as a human being, wherein the at least one polyether polyol has a molecular weight of from 200 to 4000 and is dissolved in the aqueous fluid in a concentration of from 0.01 to 10 mg/ml, preferably from 1 to 10 mg/ml.
    Type: Application
    Filed: December 23, 2005
    Publication date: November 27, 2008
    Applicant: UNIVERSITY COLLEGE LONDON HOSPITALS NHS FOUNDATION
    Inventors: Gareth Ackland, Alexander V. Gourine